Menu
Recruiting NCT07277673

Aerobic Exercise Addition to Cognitive Behavioural Treatment in Impotence Metabolic-syndrome Drinkers

No phase Interventional Heavy Drinking Metabolic Syndrome Impotence

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: aerobci physical training and cognitive behavioural treatment, Cognitive behavioural treatment.
Who it may be relevant to
Registry conditions: Heavy Drinking, Metabolic Syndrome, Impotence. Basic parameters: 35 years — 45 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Is There a Benefit of Aerobic Exercise Addition to Cognitive Behavioural Treatment in Heavy Drinking Men With Impotence and Metabolic Syndrome?

Overview

Cognitive Behavioural Treatment is used as treatment for Heavy Drinking, Impotence, and Metabolic Syndrome. The efficacy of adding aerobic training to this treatment is not tested till now.

Detailed description

Forty men with Heavy Drinking, Impotence, and Metabolic Syndrome will be included. catogorization will be performed to assign them to group number I or group number II. Every group will involve/contain twenty males. Both groups will receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks). Also, Group number I will also adminsiter supervised aerobic training (walking on electrical treamill, 50 minute per the session , three times/week, for 12 weeks).

Interventions

  • Behavioral aerobci physical training and cognitive behavioural treatment
    Twenty men with Heavy Drinking, Impotence, and Metabolic Syndrome receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks). Also, men will also adminsiter supervised aerobic training (walking on electrical treamill, 50 minute per the session, three times/week, for 12 weeks).
  • Behavioral Cognitive behavioural treatment
    Twenty men with Heavy Drinking, Impotence, and Metabolic Syndrome will receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks)

Primary outcome measures

  • international index of erectile function [Time frame: it will be measured after 12 weeks]
Secondary outcome measures (12)
  • body mass index [Time frame: It will be measured after 12 weeks]
  • waist circumference [Time frame: It will be measured after 12 weeks]
  • blood systolic pressure [Time frame: It will be measured after 12 weeks]
  • blood diastolic pressure [Time frame: it will be measured after 12 weeks]
  • triglycerides [Time frame: It will be measured after 12 weeks]
  • high density lipoproteins [Time frame: It will be measured after 12 weeks]
  • blood glucose [Time frame: It will be measured after 12 weeks]
  • Alcohol abstinence self-efficacy [Time frame: It will be measured after 12 weeks]
  • negative affect [Time frame: It will be measured after 12 weeks]
  • Positive and social affect [Time frame: It will be measured after 12 weeks]
  • physical and other concerns [Time frame: It will be measured after 12 weeks]
  • craving and urges [Time frame: It will be measured after 12 weeks]

Eligibility criteria

Inclusion criteria

  • heavy drinking men (forty)
  • men who complain metabolic syndrome
  • men who complain impotence

Exclusion criteria

  • cardiac problems
  • renal or hepatic or respiratory or neurogenic diseases,

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Giza

Identifiers

NCT: NCT07277673 · IRB000-14233-55

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗